Adding to the pressure is that CVS Health has retained coverage of Zepbound's arch rival Wegovy (semaglutide), sold by Novo ...

Gland Pharma Limited, a generic injectable & ophthalmic focused pharmaceutical company, has received approval from the USFDA ...

The company's approved ANDA is therapeutically equivalent to AstraZeneca Pharmaceuticals's Brilinta Tablets, 60 mg and 90 mg, it added.

Amneal Pharmaceuticals, Inc. ( NASDAQ: AMRX) Q1 2025 Earnings Call May 2, 2025 8:30 AM ET Tony DiMeo - Head, Investor Relations Chirag Patel - Co-Founder and Co-Chief Executive Officer Chintu Patel - ...

Alembic Pharmaceuticals receives FDA approval for Ticagrelor Tablets 60 mg and 90 mg, therapeutically equivalent to Brilinta.

May 1, 2025Phathom Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is $-1.31 EPS, expectations were $-1.06. Operator: Hello and welcome to the Phathom Pharmaceuticals’ First ...

Alembic Pharmaceuticals secured USFDA approval to market generic Ticagrelor tablets, 90 mg, aimed at preventing heart attack ...

Alembic Pharmaceuticals (Alembic) today announced that it has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Ticagrelor Tablets, ...

Alembic Pharmaceuticals announced that it has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Ticagrelor Tablets, 90 mg, and ...

Alembic Pharmaceuticals has received USFDA approval to market generic Ticagrelor Tablets, a medication for preventing heart ...

Alembic Pharmaceuticals secured USFDA approval to market generic Ticagrelor Tablets for heart attack and stroke prevention, ...

Vadodara: Alembic Pharmaceuticals Limited has announced that the US Food & Drug Administration (USFDA) has given final ...